Greg Stephens

Opanga Networks is the global leader in the development and deployment of machine learning-powered software solutions for the telecommunications industry. Opanga’s cloud-native applications increase efficiency and provide actionable insights to drastically drive down capital and operating expenses for network operators of all sizes, while enhancing speed and performance for end-users. Our team of data scientists, software engineers and business operations experts have deep experience across the telecommunications industry and is delivering on its innovation promise around the world. Together, we are committed to applying the power of AI/ML to transform telecom for the collective benefit of investors, shareholders, and consumers alike.

Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.

Spectrum Effect’s mission is to solve the most challenging and costly problems in the wireless industry through innovation and automation. Spectrum Effects industry-leading Spectrum-NET solution automates the analysis of RF interference. Protected by 30 issued patents, Spectrum-NET performs machine learning-driven analysis of RF interference across all RF bands and operates seamlessly across multi-vendor 5G NR, LTE, and UMTS cells within mobile networks. Operators across the globe are using Spectrum-NET to rapidly address RF interference, improve network KPIs, surgically deploy field assets, gain key insights into spectral efficiency, and save significant OPEX and CAPEX. Spectrum Effect has offices in Kirkland, Washington, USA, and San Pedro Garza Garcia, Mexico.

Opanga Networks is the global leader in the development and deployment of machine learning-powered software solutions for the telecommunications industry. Opanga’s cloud-native applications increase efficiency and provide actionable insights to drastically drive down capital and operating expenses for network operators of all sizes, while enhancing speed and performance for end-users. Our team of data scientists, software engineers and business operations experts have deep experience across the telecommunications industry and is delivering on its innovation promise around the world. Together, we are committed to applying the power of AI/ML to transform telecom for the collective benefit of investors, shareholders, and consumers alike.

Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.

Spectrum Effect’s mission is to solve the most challenging and costly problems in the wireless industry through innovation and automation. Spectrum Effects industry-leading Spectrum-NET solution automates the analysis of RF interference. Protected by 30 issued patents, Spectrum-NET performs machine learning-driven analysis of RF interference across all RF bands and operates seamlessly across multi-vendor 5G NR, LTE, and UMTS cells within mobile networks. Operators across the globe are using Spectrum-NET to rapidly address RF interference, improve network KPIs, surgically deploy field assets, gain key insights into spectral efficiency, and save significant OPEX and CAPEX. Spectrum Effect has offices in Kirkland, Washington, USA, and San Pedro Garza Garcia, Mexico.